Last reviewed 2026-04-22 · How we verify

anti spasmodic agents

Antispasmodic agents reduce muscle contractions and spasms by inhibiting smooth muscle contraction in the gastrointestinal tract and other organs.

Antispasmodic agents reduce muscle contractions and spasms by inhibiting smooth muscle contraction in the gastrointestinal tract and other organs. Used for Irritable bowel syndrome, Functional gastrointestinal disorders with spasms, Abdominal pain and cramping.

At a glance

Mechanism of action

These drugs work through multiple mechanisms including anticholinergic activity, direct smooth muscle relaxation, or calcium channel modulation to decrease involuntary muscle contractions. They are commonly used to relieve symptoms of gastrointestinal disorders characterized by abnormal muscle contractions, such as irritable bowel syndrome and functional bowel disorders.

Approved indications

• Irritable bowel syndrome
• Functional gastrointestinal disorders with spasms
• Abdominal pain and cramping

Common side effects

• Dry mouth
• Constipation
• Dizziness
• Blurred vision

Key clinical trials

• Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS) (PHASE4)
• Patient Attributes for Optimal Treatment Outcome in Irritable Bowel Syndrome. (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• anti spasmodic agents CI brief — competitive landscape report
• anti spasmodic agents updates RSS · CI watch RSS
• Laboratoires Mayoly Spindler portfolio CI